Imexon

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Imexon
Imexon.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ECHA InfoCard 100.056.199
Chemical and physical data
Formula C4H5N3O
Molar mass 111.102 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

External links[edit]

  • Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".